Egf Theramed Health Stock Revenue
| EVAHF Stock | USD 0.21 0.00 0.00% |
EGF Theramed Health fundamentals help investors to digest information that contributes to EGF Theramed's financial success or failures. It also enables traders to predict the movement of EGF Pink Sheet. The fundamental analysis module provides a way to measure EGF Theramed's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EGF Theramed pink sheet.
EGF |
EGF Theramed Health Company Revenue Analysis
EGF Theramed's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, EGF Theramed Health reported 0.0 of revenue. This is 100.0% lower than that of the Healthcare sector and about the same as Health Information Services (which currently averages 0.0) industry. The revenue for all United States stocks is 100.0% higher than that of the company.
EGF Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EGF Theramed's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of EGF Theramed could also be used in its relative valuation, which is a method of valuing EGF Theramed by comparing valuation metrics of similar companies.EGF Theramed is currently under evaluation in revenue category among its peers.
EGF Fundamentals
| Return On Equity | -2.11 | |||
| Return On Asset | -0.72 | |||
| Current Valuation | 4.72 M | |||
| Shares Outstanding | 10.49 M | |||
| Shares Owned By Insiders | 0.09 % | |||
| Price To Book | 42.04 X | |||
| Gross Profit | (105.22 K) | |||
| EBITDA | (1.35 M) | |||
| Net Income | (1.35 M) | |||
| Cash And Equivalents | 51.98 K | |||
| Cash Per Share | 0.02 X | |||
| Total Debt | 1.23 M | |||
| Debt To Equity | 6.69 % | |||
| Current Ratio | 0.10 X | |||
| Book Value Per Share | (0.08) X | |||
| Cash Flow From Operations | (993.42 K) | |||
| Earnings Per Share | 0.01 X | |||
| Beta | 1.55 | |||
| Market Capitalization | 12.41 M | |||
| Total Asset | 178.67 K | |||
| Z Score | -17.1 | |||
| Net Asset | 178.67 K |
About EGF Theramed Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EGF Theramed Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EGF Theramed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EGF Theramed Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in EGF Pink Sheet
EGF Theramed financial ratios help investors to determine whether EGF Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EGF with respect to the benefits of owning EGF Theramed security.